Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
Author(s) :
Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H |
Ref :
Cancer Chemother Pharmacol , 70 :25 , 2012 |
Abstract : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
ESTHER : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
PubMedID: 22610353 |